George Harrison Talbot's Net Worth

$50.4 Thousand

Estimate Recalculated Sep 8, 2024 07:30PM EST

Who is George Harrison Talbot?

George Harrison Talbot does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, Nabriva Therapeutics AG, and Durata Therapeutics, Inc..

SEC CIK

George Harrison Talbot's CIK is 0001554194

Past Insider Trading and Trends

2017 was George Harrison Talbot's most active year for acquiring shares with 8 total transactions. George Harrison Talbot's most active month to acquire stocks was the month of June. 2017 was George Harrison Talbot's most active year for disposing of shares, totalling 15 transactions. George Harrison Talbot's most active month to dispose stocks was the month of April. 2018 saw George Harrison Talbot paying a total of $39,875.00 for 43,500 shares, this is the most they've acquired in one year. In 2017 George Harrison Talbot cashed out on 3,490 shares for a total of $90,276.90, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nabriva Therapeutics Plc No price found

Investor

George Harrison Talbot owns 31,790 units of Ordinary Shares. In the year 2017 George Harrison Talbot filed a total of 1 filing.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
31.79K
—
—
31.79K
Jun 23
No matching records found

Nabriva Therapeutics AG (NBRVF) Snapshot price: $0.000001

Investor

George Harrison Talbot owns 3,179 units of Common Shares which is worth $0.00 and 65,140 units of Ordinary Shares which is worth $0.07. In the year 2016 George Harrison Talbot acquired a total of 34,585 shares in Nabriva Therapeutics AG at a cost of $39,875.00, George also disposed a total of 905 shares of Nabriva Therapeutics AG equalling to $90,276.90.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+36.73%
17.5K
—
—
65.14K
Jul 29
Form 4
—
0
—
—
0
Jul 31
Form 4
+43.75%
14.5K
$2.75
$39,875.00
47.64K
Jul 31
Form 4
—
0
—
—
0
May 2
Form 4
+4.25%
1.35K
—
—
33.14K
Sep 27
Form 4
—
0
—
—
0
Sep 15
Form 4
-5.08%
-170.00
$93.18
-$15,840.00
3.18K
Jun 15 - Jun 19
Form 4
-5.90%
-210.00
$101.26
-$21,265.00
3.35K
May 30
Form 4
-8.37%
-325.00
$100.56
-$32,683.50
3.56K
May 23 - May 25
Form 4
+36.33%
1.03K
$102.44
-$20,488.40
3.88K
Feb 16 - May 16
Form 3
—
0
—
—
0
No matching records found

Durata Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found